Q1 2019 Holdings
Filed 2019-05-15 | 79 holdings | $35.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atricure Inc(ATRC) | COM | 04963C209 | $8.5M | 318,729 | 23.9% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $5.9M | 715,538 | 16.4% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $5.2M | 44,380 | 14.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $4.5M | 35,650 | 12.5% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $4.1M | 498,415 | 11.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $3.2M | 400,294 | 9.1% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $1.9M | 676,759 | 5.3% |
| Alector Inc(ALEC) | COM | 014442107 | $918.0K | 49,063 | 2.6% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $884.0K | 246,900 | 2.5% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $452.0K | 50,000 | 1.3% |
| Stereotaxis Inc(STXS) | COM | 85916J409 | $26.7K | 13,680,554 | 0.1% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $19.7K | 123,806 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $9.6K | 119,718 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $7.8K | 571,013 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $7.4K | 190,554 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $7.2K | 151,770 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $7.1K | 129,764 | 0.0% |
| Ishares TR Nasdaq Biotech(IBB) | ETF | 464287556 | $6.9K | 61,400 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $5.8K | 49,609 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $4.8K | 55,008 | 0.0% |
| Menlo Therapeutics Inc | COM | 586858102 | $4.7K | 600,030 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $4.2K | 27,000 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $4.2K | 93,942 | 0.0% |
| Biohaven Pharmaceuticals Hold(BHVN) | COM | G11196105 | $4.1K | 80,000 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $3.9K | 32,338 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $3.7K | 278,811 | 0.0% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $3.6K | 261,521 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.4K | 330,667 | 0.0% |
| Radius Health Inc | NOTE 3.000% 9/0 | 750469AA6 | $3.3K | $4,000,000 | 0.0% |
| Luminex Corp | COM | 55027E102 | $3.2K | 138,391 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $3.0K | 808,000 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $2.8K | 143,611 | 0.0% |
| Intec Pharma LTD Jerusalem | SHS | M53644106 | $2.8K | 381,789 | 0.0% |
| Biotelemetry Inc(BEATEUR) | COM | 090672106 | $2.2K | 34,800 | 0.0% |
| Cardiovascular Systems Inc(CSIIEUR) | COM | 141619106 | $2.2K | 56,200 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $2.1K | 403,300 | 0.0% |
| Corbus Pharmaceuticals Hldgs(CRBPEUR) | COM | 21833P103 | $2.1K | 305,000 | 0.0% |
| Kadmon Holdings Inc(KDMN) | COM | 48283N106 | $2.0K | 757,177 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $2.0K | 31,210 | 0.0% |
| Scynexis Inc | COM | 811292101 | $1.9K | 1,272,927 | 0.0% |
| Achillion Pharmaceuticals(ACHNEUR) | COM | 00448Q201 | $1.8K | 621,182 | 0.0% |
| Insulet Corp | NOTE 1.375% | 45784PAG6 | $1.8K | $1,500,000 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $1.8K | 123,314 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $1.8K | 373,164 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $1.8K | 179,200 | 0.0% |
| VBI Vaccines Inc(VAC2USD) | COM NEW | 91822J103 | $1.6K | 850,000 | 0.0% |
| Applied Genetic Technol Corp(2GT) | COM | 03820J100 | $1.5K | 359,190 | 0.0% |
| Johnson and Johnson(JNJ) | COM | 478160104 | $1.3K | 9,400 | 0.0% |
| Advaxis Inc(ADXSEUR) | COM NEW | 007624307 | $1.2K | 202,222 | 0.0% |
| Genocea Biosciences Inc | COM | 372427104 | $1.2K | 1,989,653 | 0.0% |